New Drugs FDA Approves NexoBrid (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults 1 year ago
New Drugs FDA Approves Briumvi (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis 1 year ago
New Drugs FDA Approves Xenoview (xenon Xe 129 hyperpolarized) for use with MRI for the Evaluation of Lung Ventilation 1 year ago
New Drugs FDA Approves Olpruva (sodium phenylbutyrate) for Patients with Urea Cycle Disorders 1 year ago
New Drugs FDA Approves Once-Weekly Wegovy injection for the Treatment of Obesity in Teens Aged 12 Years and Older 1 year ago
New Drugs FDA Approves Lunsumio (mosunetuzumab-axgb) for the Treatment of Relapsed or Refractory Follicular Lymphoma 1 year ago
New Drugs FDA Approves Sunlenca (lenacapavir) Twice-Yearly Treatment for People Living With Multi-Drug Resistant HIV 1 year ago
New Drugs FDA Approves Genentech’s Actemra for the Treatment of COVID-19 in Hospitalized Adults 1 year ago
New Drugs Radius Health’s Tymlos (abaloparatide) Receives U.S. FDA Approval as a Treatment to Increase Bone Density in Men with Osteoporosis at High Risk for Fracture 1 year ago
New Drugs Eagle Pharmaceuticals Receives FDA Approval for Additional Indication for Pemfexy in Combination with Pembrolizumab and Platinum Chemotherapy 1 year ago